Faron Pharmaceuticals OY (FARN) NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
117.50p
118.30p
360.00p
£84.61 million
118.00p
113.00p
113.00p
n/a
2.00p (1.67%) Previous:
2.00p
4,573
n/a
1,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (€m) | n/a | n/a |
Profit before tax (€m) | (30.94) | (28.73) |
Adjusted EPS (¢): | (48.00) | (52.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: Euro
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Faron Pharmaceuticals CFO stands down
15 April 2024 09:36
-
Faron Pharmaceuticals taps Juho Jalkanen for CEO
8 April 2024 09:17
-
Faron shares jump on encouraging trial data
18 March 2024 14:14
-
Appointment of Chief Financial Officer
15 April 2024 07:00
-
Approval of Warrant Terms and Conditions
8 April 2024 07:10
-
Decisions of the Board of Directors
8 April 2024 07:05
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.